These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13818707)

  • 1. The use of syrosingopine (SU-3118) and hydralazine in ambulatory hypertensive patients.
    DUNSMORE RA; DUNSMORE LD; ELIAS M
    Am J Med Sci; 1960 Feb; 239():148-53. PubMed ID: 13818707
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results in the therapy of hypertension with reserpine, dihydrazinophthalazine, a combination of both and placebos].
    BENGOLEA A; BASTAROLI J
    Prensa Med Argent; 1959 Jul; 46():1701-6. PubMed ID: 13798865
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined treatment of hypertension].
    FARIA RD
    Dia Med; 1962 Mar; 34():236-7. PubMed ID: 13891619
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reserpine-hydrazinophthalazine-hydrochlorothiazide combination in the treatment of hypertension].
    GALLI G
    Clin Ter; 1962 Jun; 22():1104-16. PubMed ID: 13896437
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged hydralazine hydrochloride administration in 132 hypertensive patients--Study of toxicity.
    PIGEON G; GENEST J
    Can Med Assoc J; 1960 Oct; 83(14):743-6. PubMed ID: 13735669
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contribution to the treatment of arterial hypertension with the use of a combination of hypotensive drugs].
    GARBINI GC; PEDRAZZI F; POPPI A
    Minerva Med; 1961 Aug; 52():2805-34. PubMed ID: 13703467
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of syrosingopine and reserpine in the treatment of ambulatory hypertensive patients.
    SHELBURNE PF; ORGAIN ES
    Am J Med Sci; 1963 Mar; 245():304-10. PubMed ID: 13977067
    [No Abstract]   [Full Text] [Related]  

  • 8. Reserpine-hydralazine combination therapy of hypertensive disease, with hydralazine in doses generally below the toxic range.
    LEE RE; SELIGMANN AM; GOEBEL D; FULTON LA; CLARK MA
    Ann Intern Med; 1956 Mar; 44(3):456-65. PubMed ID: 13303018
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative observations of reserpine and syrosingopine.
    WINER BM; SAHAY BM
    N Engl J Med; 1960 Dec; 263():1165-9. PubMed ID: 13785789
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduced sedative effect of a newly synthesized reserpine derivative (syrosingopine): clinical appraisal in primary hypertension.
    CALESNICK B
    J Am Geriatr Soc; 1959 Aug; 7(8):648-55. PubMed ID: 13672741
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of hypertension with orally given syrosingopine.
    HERRMANN GR; VOGELPOHL EB; HEJTMANCIK MR; WRIGHT JC
    J Am Med Assoc; 1959 Apr; 169(14):1609-12. PubMed ID: 13640910
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydralazine in the treatment of hypertension.
    MOYER JH; BREST AN
    Med Clin North Am; 1961 Mar; 45():375-83. PubMed ID: 13773375
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology and clinical use of hydralazine in the treatment of diastolic hypertension.
    SCHIRGER A; SPITTELL JA
    Am J Cardiol; 1962 Jun; 9():854-9. PubMed ID: 14498465
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the addition of hydralazine or chlorothiazide to ganglionic blocking agents in the treatment of severe hypertension.
    BLAQUIER P; HOOBLER SW
    Am J Med Sci; 1959 Dec; 238():740-6. PubMed ID: 13801343
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiating the hypotensive effect of hydrochlorothiazide with syrosingopine.
    KOLODNY AL; DABOLINS R
    Angiology; 1960 Jun; 11():180-5. PubMed ID: 14410751
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypotensive properties of syrosingopine SU-3118, an ester of methyl reserpate.
    PLUMMER AJ; BARRETT WE; MAXWELL RA; FINOCCHIO D; LUCAS RA; EARL AE
    Arch Int Pharmacodyn Ther; 1959 Mar; 119(1-2):245-57. PubMed ID: 13628284
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hypertension with reserpine (serpasil) alone and in combination with hydralazine (apresoline).
    STUPPY LJ; TOBER JN
    Angiology; 1955 Jun; 6(3):253-9. PubMed ID: 13275730
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of piezogram in indications and results of the treatment of hypertension with hydralazine and reserpine].
    DONZELOT E; MEYER-HEINE A; METIANU C; KERVOELEN P; SERAFINI V
    Acta Med Scand Suppl; 1956; 312():199-205. PubMed ID: 13339168
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methonium compounds, hydrazinophthalazine and reserpine in therapy of hypertension].
    DE WITTE P
    Acta Clin Belg; 1954; 9(3):193-218. PubMed ID: 13188579
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of hypertension with oral reserpine alone and in combination with hydralazine or hexamethonium.
    HUGHES WM; DENNIS E; MOYER JH
    Am J Med Sci; 1955 Feb; 229(2):121-34. PubMed ID: 13228421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.